Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Environmental factors can trigger alopecia areata in identical twins.

Accurate diagnosis of hair loss types is crucial for effective treatment.

More research is needed to understand genetic causes and create better treatments for alopecia areata.

Severe alopecia areata in children can signal future autoimmune issues.

Baricitinib is a promising treatment for alopecia areata.

Some children may develop hair loss after having COVID-19.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Depression and hair loss may influence each other.

Accurate diagnosis and understanding of alopecia areata in children are crucial for proper treatment.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Differences in skin and gut bacteria may contribute to alopecia areata.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

Squaric acid dibutylester effectively treats alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Greying hairs may be protected from alopecia areata.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Hair loss treatment caused more hair loss in a man.

Hair color is not a risk factor for developing alopecia areata.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.